Here’s a great article on the potential benefits and high risks of 5-MeO-DMT from the Bufo toad… Along with the carelessness and unethical behavior of fake guru Octavio Rettig.
Read moreResearching Psychedelics- It's Complicated
Researchers from SUNY Downstate Health Sciences University and McGill University published a paper in the journal Science Advances proposing a unique method for better understanding the interaction between hallucinogenic drugs, people’s brains, and different types of psychedelic experiences.
They did this by using artificial intelligence to look at real-life accounts of psychedelic experiences and compare them to how human brain chemistry engages with drugs on a molecular level.
However, while the researchers’ methods and goals push the envelope forward on understanding how psychedelics can help or harm individuals, the data they use could be unreliable.
Read moreMicrodosing Research- Mixed Results
This article breaks down the current trend of microdosing, and the lack of solid research.
Read moreRisks of Psychedelics
Before psychedelic therapy and services becomes widely available, there needs to be a better understanding of all the ways these experiences can go wrong.
Read morePsilocybin for Depression Is Effective for One Year
New research shows that psilocybin treatment for major depression is effective for up to a year for most patients.
Read moreKetamine for Suicidal Thoughts
A new study shows that Ketamine effectively silences suicidal thoughts, especially in bipolar patients.
The effects wore off after 4-6 weeks however.
Read moreDMT and Depression
The first clinical trial using DMT for depression has promising results.
Read moreMore Research on Psychedelics
Here’s a look at the most recent, promising research on psychedelics and mental health.
Read morePsychedelics for Pain?
Some scientists believe that LSD and psilocybin could treat everything from cluster headaches to fibromyalgia.
Read more